Seizert Capital Partners, LLC United Therapeutics Corp Transaction History

Seizert Capital Partners, LLC

  • $2.16 Billion
  • Q3 2024

A detailed history of Seizert Capital Partners, LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Seizert Capital Partners, LLC holds 38,906 shares of UTHR stock, worth $14.5 Million. This represents 0.65% of its overall portfolio holdings.

Number of Shares
38,906
Previous 24,441 59.18%
Holding current value
$14.5 Million
Previous $7.79 Million 79.08%
% of portfolio
0.65%
Previous 0.4%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024
BUY
$311.04 - $363.55 $4.5 Million - $5.26 Million
14,465 Added 59.18%
38,906 $13.9 Million
Q2 2024

Aug 07, 2024
SELL
$228.26 - $319.04 $190,368 - $266,079
-834 Reduced 3.3%
24,441 $7.79 Million
Q1 2024

May 01, 2024
BUY
$210.76 - $249.51 $42,362 - $50,151
201 Added 0.8%
25,275 $5.81 Million
Q4 2023

Feb 07, 2024
SELL
$214.88 - $256.94 $877,569 - $1.05 Million
-4,084 Reduced 14.01%
25,074 $5.51 Million
Q3 2023

Nov 06, 2023
BUY
$211.82 - $248.24 $800,044 - $937,602
3,777 Added 14.88%
29,158 $6.59 Million
Q2 2023

Jul 27, 2023
SELL
$205.19 - $232.99 $64,634 - $73,391
-315 Reduced 1.23%
25,381 $5.6 Million
Q1 2023

May 09, 2023
BUY
$212.99 - $276.17 $5.47 Million - $7.1 Million
25,696 New
25,696 $5.75 Million
Q4 2022

Jan 30, 2023
SELL
$205.95 - $280.43 $1.47 Million - $1.99 Million
-7,114 Reduced 20.8%
27,091 $7.53 Million
Q3 2022

Nov 02, 2022
SELL
$203.3 - $244.17 $94,127 - $113,050
-463 Reduced 1.34%
34,205 $7.16 Million
Q2 2022

Aug 04, 2022
SELL
$174.81 - $241.14 $1.44 Million - $1.99 Million
-8,238 Reduced 19.2%
34,668 $8.17 Million
Q1 2022

May 03, 2022
SELL
$166.16 - $213.96 $93,049 - $119,817
-560 Reduced 1.29%
42,906 $7.7 Million
Q4 2021

Feb 08, 2022
SELL
$184.32 - $216.08 $1.22 Million - $1.44 Million
-6,643 Reduced 13.26%
43,466 $9.39 Million
Q3 2021

Nov 03, 2021
BUY
$179.86 - $214.88 $364,396 - $435,346
2,026 Added 4.21%
50,109 $9.25 Million
Q2 2021

Aug 05, 2021
SELL
$170.47 - $211.93 $4.92 Million - $6.12 Million
-28,857 Reduced 37.51%
48,083 $8.63 Million
Q1 2021

May 05, 2021
SELL
$153.94 - $174.85 $40,178 - $45,635
-261 Reduced 0.34%
76,940 $12.9 Million
Q4 2020

Feb 08, 2021
SELL
$101.87 - $151.79 $672,545 - $1 Million
-6,602 Reduced 7.88%
77,201 $11.7 Million
Q3 2020

Nov 03, 2020
BUY
$99.9 - $121.13 $1.02 Million - $1.24 Million
10,197 Added 13.85%
83,803 $8.46 Million
Q2 2020

Aug 06, 2020
SELL
$92.74 - $125.82 $785,600 - $1.07 Million
-8,471 Reduced 10.32%
73,606 $8.91 Million
Q1 2020

May 05, 2020
BUY
$79.39 - $115.35 $6.52 Million - $9.47 Million
82,077 New
82,077 $7.78 Million

Others Institutions Holding UTHR

# of Institutions
669
Shares Held
42.8M
Call Options Held
194K
Put Options Held
295K
View Full List

About UNITED THERAPEUTICS Corp

UTHR Quotes by TradingView
  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $17B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Seizert Capital Partners, LLC Portfolio

Follow Seizert Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Seizert Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Seizert Capital Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email